Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Drug company won't appeal gay rights ruling to top U.S. court

Tue, 05th Aug 2014 22:13

(Adds details about case)

By Dan Levine

SAN FRANCISCO, Aug 5 (Reuters) - An appeals court rulingthat extended landmark constitutional protections for gays andlesbians will not be appealed to the U.S. Supreme Court, aspokesman for one of the drug companies in the case said onTuesday.

The issue began when a gay man was excluded from juryservice in a lawsuit brought by GlaxoSmithKline againstAbbVie over HIV pricing. The San Francisco-based 9thU.S. Circuit Court of Appeals in January had found that the manwas improperly excluded because of his sexual orientation.

The court's January opinion heightened constitutionalprotections judges in several Western states must now apply whenevaluating laws that curtail gay rights.

AbbVie spokesman Dirk Van Eeden said on Tuesday the companywould not ask the U.S. Supreme Court to review the 9th Circuit'sfindings. A Glaxo representative could not immediately bereached for comment.

The case involved Abbott's pricing of HIV medications, acontentious issue in the gay community. Glaxo accused Abbott ofimproperly increasing the price of one drug, Norvir, to help itpreserve sales growth of one of its other HIV blockbusters,Kaletra.

Norvir plays a key role in AIDS-fighting cocktails becauseit can boost the effectiveness of other drugs. Glaxo accusedAbbott of raising Norvir's price by 400 percent in 2003 as partof an effort to harm competitors whose drugs were dependent onbeing used in combination with Norvir.

Glaxo had sought $571 million, but after a four-week trialin 2011 came away with only a $3.5 million jury award. The 9thCircuit ordered a new trial between Glaxo and AbbVie, an AbbottLaboratories spinoff.

In its January ruling, the 9th Circuit cited United Statesv. Windsor, the U.S. Supreme Court decision last year thatstruck down part of the federal Defense of Marriage Act (DOMA).Given the legal reasoning in Windsor, the 9th Circuit held thatgays and lesbians deserve some of the same constitutionalprotections as those enjoyed by African-Americans and women.

Juror strikes based on sexual orientation "depriveindividuals of the opportunity to participate in perfectingdemocracy and guarding our ideals of justice on account of acharacteristic that has nothing to do with their fitness toserve," 9th Circuit Judge Stephen Reinhardt wrote.

The case in the 9th U.S. Circuit Court of Appeals isSmithkline Beecham Corp dba GlaxoSmithKline vs. AbbottLaboratories, No. 11-17357. (Reporting by Dan Levine; Editing by Leslie Adler and AndrewHay)

More News
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.